ClinConnect ClinConnect Logo
Search / Trial NCT05063331

Patient-Centered Outcomes in the Surgical Treatment of Uterovaginal Prolapse

Launched by UNIVERSITY HOSPITALS CLEVELAND MEDICAL CENTER · Sep 29, 2021

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Sacrocolpopexy Uterosacral Ligament Suspension

ClinConnect Summary

This clinical trial is looking to find out which of two surgical options works better for women with uterovaginal prolapse, a condition where the uterus drops into the vaginal canal. The researchers want to understand not just which surgery is more effective, but also which one has fewer complications in the short and long term from the perspective of the patients themselves.

To participate in this study, women need to be between 18 and 80 years old and have been diagnosed with symptomatic uterovaginal prolapse. They should be planning to have surgery and eligible for both types being compared: a minimally invasive procedure or a total vaginal hysterectomy with a specific support technique. Participants can expect to share their experiences and outcomes after surgery, helping to improve future treatment options for others. This trial is currently recruiting participants, so if you or someone you know fits the criteria, it could be a valuable opportunity to contribute to important research.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • 1. Women ≥ 18 years of age and ≤ 80 years of age
  • 2. Have diagnosis of symptomatic uterovaginal prolapse
  • 3. Have elected to undergo surgical management of uterovaginal prolapse after consultation with their physician
  • 4. Are eligible for both minimally invasive supracervical hysterectomy with sacrocolpopexy (MI-SCH+SCP) and total vaginal hysterectomy with uterosacral ligament suspension (TVH+USLS)
  • Exclusion Criteria:
  • 1. Patients who wish to undergo uterine sparing procedures
  • 2. Body mass index BMI) \> 50
  • 3. Previous hysterectomy or prior uterovaginal surgery
  • 4. Have a diagnosis of neurogenic bladder, Parkinson's disease, multiple sclerosis, spinal cord injury, or cerebrovascular accident
  • 5. Chronic indwelling urinary catheter
  • 6. Urinary diversion of any type
  • 7. Any condition or disorder that, in the opinion of the investigator, might prevent the subject from completing the study or interfere with the interpretation of the study results
  • 8. Unable to speak, read, understand English

About University Hospitals Cleveland Medical Center

University Hospitals Cleveland Medical Center is a leading academic medical center renowned for its commitment to advancing healthcare through innovative research and clinical excellence. Affiliated with Case Western Reserve University, the center integrates cutting-edge medical education, comprehensive patient care, and pioneering clinical trials to enhance treatment options and improve patient outcomes. With a diverse range of specialized programs and a robust infrastructure for research, University Hospitals Cleveland Medical Center plays a vital role in translating scientific discoveries into effective therapies, ensuring access to the latest advancements in medicine for patients and communities.

Locations

Cleveland, Ohio, United States

Jacksonville, Florida, United States

Cleveland, Ohio, United States

Cleveland, Ohio, United States

Durham, North Carolina, United States

Chicago, Illinois, United States

Pittsburgh, Pennsylvania, United States

Patients applied

0 patients applied

Trial Officials

Adonis Hijaz, MD

Principal Investigator

University Hospitals Cleveland Medical Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials